Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Amiodarone - Sonus Pharmaceuticals

Drug Profile

Amiodarone - Sonus Pharmaceuticals

Alternative Names: S 2646; Tocosol Amiodarone

Latest Information Update: 04 Apr 2008

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Sonus Pharmaceuticals
  • Class Benzofurans; Class III antiarrhythmics; Heart failure therapies; Small molecules
  • Mechanism of Action Beta-adrenergic receptor antagonists; KATP channel inhibitors; Sodium channel antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Ventricular arrhythmias

Most Recent Events

  • 04 Apr 2008 Discontinued - Preclinical for Ventricular arrhythmias in USA (unspecified route)
  • 01 Jun 2005 No development reported - Preclinical for Ventricular arrhythmias in USA (unspecified route)
  • 15 Oct 2002 Preclinical trials in Ventricular arrhythmias in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top